2GYP

Diabetes mellitus due to a frustrated Schellman motif in HNF-1a

External Resource: Annotation

Domain Annotation: ECOD Classification
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations
Protein Modification Annotation

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	HNF-1_N_N	e2gypA1	A: alpha duplicates or obligate multimers	X: Dimerisation interlock	H: Dimerization cofactor of HNF-1 alpha (From Topology)	T: Dimerization cofactor of HNF-1 alpha	F: HNF-1_N_N	ECOD (1.6)
B	HNF-1_N_N	e2gypB1	A: alpha duplicates or obligate multimers	X: Dimerisation interlock	H: Dimerization cofactor of HNF-1 alpha (From Topology)	T: Dimerization cofactor of HNF-1 alpha	F: HNF-1_N_N	ECOD (1.6)

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B	Hepatocyte nuclear factor 1-alpha	DNA binding sequence-specific DNA binding sequence-specific double-stranded DNA binding transcription cis-regulatory region binding binding double-stranded DNA binding organic cyclic compound binding nucleic acid binding transcription regulatory region nucleic acid binding RNA polymerase II transcription regulatory region sequence-specific DNA binding cis-regulatory region sequence-specific DNA binding RNA polymerase II cis-regulatory region sequence-specific DNA binding protein heterodimerization activity protein binding DNA binding sequence-specific DNA binding sequence-specific double-stranded DNA binding transcription cis-regulatory region binding binding double-stranded DNA binding organic cyclic compound binding nucleic acid binding transcription regulatory region nucleic acid binding RNA polymerase II transcription regulatory region sequence-specific DNA binding cis-regulatory region sequence-specific DNA binding RNA polymerase II cis-regulatory region sequence-specific DNA binding protein heterodimerization activity protein binding protein dimerization activity transcription regulator activity DNA-binding transcription factor activity DNA-binding transcription factor activity, RNA polymerase II-specific identical protein binding protein homodimerization activity DNA-binding transcription activator activity, RNA polymerase II-specific DNA-binding transcription activator activity	developmental process multicellular organism development multicellular organismal process hepaticobiliary system development gland development animal organ development anatomical structure development liver development system development regulation of cellular process positive regulation of DNA-templated transcription positive regulation of biological process RNA metabolic process positive regulation of macromolecule biosynthetic process developmental process multicellular organism development multicellular organismal process hepaticobiliary system development gland development animal organ development anatomical structure development liver development system development regulation of cellular process positive regulation of DNA-templated transcription positive regulation of biological process RNA metabolic process positive regulation of macromolecule biosynthetic process regulation of primary metabolic process nucleobase-containing compound metabolic process RNA biosynthetic process nucleic acid biosynthetic process DNA-templated transcription positive regulation of metabolic process regulation of DNA-templated transcription initiation regulation of RNA metabolic process transcription by RNA polymerase II positive regulation of biosynthetic process positive regulation of macromolecule metabolic process regulation of nucleobase-containing compound metabolic process transcription initiation at RNA polymerase II promoter positive regulation of cellular process regulation of RNA biosynthetic process regulation of biosynthetic process regulation of transcription by RNA polymerase II regulation of biological process positive regulation of nucleobase-containing compound metabolic process positive regulation of transcription initiation by RNA polymerase II biological regulation primary metabolic process regulation of macromolecule metabolic process nucleobase-containing compound biosynthetic process gene expression positive regulation of transcription by RNA polymerase II macromolecule biosynthetic process nucleic acid metabolic process DNA-templated transcription initiation positive regulation of DNA-templated transcription initiation positive regulation of RNA metabolic process regulation of gene expression biosynthetic process positive regulation of RNA biosynthetic process regulation of transcription initiation by RNA polymerase II metabolic process cellular process regulation of macromolecule biosynthetic process regulation of DNA-templated transcription macromolecule metabolic process regulation of metabolic process pancreas development renal system process system process hexose transmembrane transport transport carbohydrate transport renal D-glucose absorption establishment of localization transmembrane transport localization D-glucose transmembrane transport renal absorption monosaccharide transmembrane transport carbohydrate transmembrane transport D-glucose import protein localization establishment of protein localization cellular localization nitrogen compound transport signaling hormone secretion cell communication protein localization to extracellular region peptide secretion secretion by cell amide transport signal release cellular macromolecule localization regulation of biological quality secretion regulation of hormone levels establishment of protein localization to extracellular region cell-cell signaling export from cell protein secretion peptide transport protein transport peptide hormone secretion macromolecule localization hormone transport insulin secretion chemical homeostasis homeostatic process glucose homeostasis carbohydrate homeostasis	cellular anatomical structure intracellular anatomical structure cytoplasm intracellular organelle organelle membraneless organelle intracellular membraneless organelle chromatin chromosome protein-containing complex membrane-bounded organelle nucleus intracellular membrane-bounded organelle

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B	IPR006897	Hepatocyte nuclear factor 1, beta isoform, C-terminal	Domain
A, B	IPR006898	Hepatocyte nuclear factor 1, alpha isoform C-terminal	Domain
A, B	IPR044869	HNF-1, POU-specific (POUs) atypical domain	Domain
A, B	IPR039066	Hepatocyte nuclear factor 1	Family
A, B	IPR023219	Hepatocyte nuclear factor 1, N-terminal domain superfamily	Homologous Superfamily
A, B	IPR044866	HNF-1, dimerization domain	Domain
A, B	IPR009057	Homedomain-like superfamily	Homologous Superfamily
A, B	IPR010982	Lambda repressor-like, DNA-binding domain superfamily	Homologous Superfamily
A, B	IPR001356	Homeodomain	Domain
A, B	IPR006899	Hepatocyte nuclear factor 1, N-terminal	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B	Pharos: P20823	maturity-onset diabetes of the young hepatic adenomas, familial maturity-onset diabetes of the young type 3 type 1 diabetes mellitus 20 type 2 diabetes mellitus renal cell carcinoma chromophobe renal cell carcinoma hyperinsulinism due to HNF1A deficiency nonpapillary renal cell carcinoma papillary renal cell carcinoma clear cell renal carcinoma type 1 diabetes mellitus hyperinsulinemic hypoglycemia hypoglycemia collecting duct carcinoma maturity-onset diabetes of the young hepatic adenomas, familial maturity-onset diabetes of the young type 3 type 1 diabetes mellitus 20 type 2 diabetes mellitus renal cell carcinoma chromophobe renal cell carcinoma hyperinsulinism due to HNF1A deficiency nonpapillary renal cell carcinoma papillary renal cell carcinoma clear cell renal carcinoma type 1 diabetes mellitus hyperinsulinemic hypoglycemia hypoglycemia collecting duct carcinoma sarcomatoid renal cell carcinoma hepatocellular adenoma hyperinsulinism IDDM 1 acquired metabolic disease non-alcoholic fatty liver disease ovarian carcinoma clear cell papillary renal cell carcinoma renal carcinoma Conventional (Clear Cell) Renal Cell Carcinoma triple-negative breast carcinoma diabetes mellitus hyperglycemia inborn errors of metabolism coronary artery disease gallbladder disease hepatobiliary neoplasm myocardial infarction osteosarcoma endogenous depression heart disease

Protein Modification Annotation

Modified Residue(s)
Chain	Residue(s)	Description
A, B	DAL	RESID: AA0111 , AA0191 PSI-MOD : meso-lanthionine MOD:00120 , D-alanine (Ala) MOD:00198 , D-alanine (Ser) MOD:00858 , D-alanine MOD:00862
A, B	NLE	Parent Component: LEU RESID: AA0111 , AA0191

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.